[Ip-health] workshop, University of Oxford-Patent Policy in Genomics and Human Genetics

Katerina Sideri katerina.sideri10 at gmail.com
Fri Jan 30 10:54:09 PST 2015


Dear all.

I would like to draw your attention to a workshop that may be of interest
to some of you. The workshop 'Patent Policy in Genomics and Human Genetics:
A Public Health Perspective' will take place at the University of Oxford on
the 11 of February 2015.
With best wishes
Dr Katerina Sideri



*Patent Policy in Genomics and Human Genetics: A Public Health Perspective*

*Workshop*

9:00–5:10, Wednesday 11 February 2015

Venue: Haldane Room, Wolfson College, Linton Road, Oxford





*9:00*– *9:30*      *Coffee and pastries*

*9:30 –9:45*      *Introduction*

*Prof Denis Galligan**,Professor of Socio-Legal Studies Oxford
University;Director of Programmes for Law Justice and Society at Wolfson;
Fellow of Wolfson College*

*Dr Katerina Sideri*, *Legal Advisor Agricultural University of Athens*

*9:45 – 10:45*   *Session I:Patenting DNA Sequences. Law and Politics in
Comparative Perspective*


*Julian Cockbain, *Consultant, European patent attorney

Title:*'Genetic Patenting in Europe and the US'*


*Prof Ingrid Schneider, *Professor*, *University of Hamburg, Germany.
Member, European Commission Expert Group on the development and
implications of patent law in the field of biotechnology and genetic
engineering

Title: *'**Epistemic Communities, Courts and the Democratic Shaping of
Patent Law’*

*10:45 – 11:15* *Tea and coffee*

*11:15 – 12:15* *Session II: **Biomarker Patenting, Monopolies, and Public
Health*

Dr Stuart Hogarth,Senior Research *Fellow, *King's College London,
University of London*Title: '**Biomarker Patents and Diagnostic Monopolies
in Comparative Perspective – Stories from the USA and the UK'* *Dr Michael
Hopkins, *Senior Lecturer, Science Policy Research Unit, *University of
Sussex*



Title:*'**Biomarker Patents versus Hidden Innovation: What Type of
Diagnostics Do We Want to Pay for?’*


*12:15– 1:15*    *Lunch*



*1:15 – 2:15*     *Session III:**The 100K Genome Project and IP Licensing*

*Prof Sigrid Sterkcx, **Professor* of Ethics, *Ghent* University and
VrijeUniversiteit *Brussel*, member, Belgian Advisory Committee on
Bioethics, ethics consultant for various EU research projects

Title: *'”**I thought our records were private not up for auction to the
highest bidder”: Ongoing controversies regarding the UKcare data scheme'*


*Dr Mark Bale,*Deputy Head, *Health* Science and Bioethics, *Department of
Health, UK Government, *Deputy Chief Scientific Adviser, UK *Department of
Health, UK*

Title: *'Diagnosis and IP in the genomics era’*


*2:15 - 3:15      Session IV: University Licensing*

*Dr Adam Stoten, *Deputy Head of Technology Transfer, ISIS Innovation
Limited, University of Oxford

Title: *'Responsible IP Management; A University Perspective'*


*Dr Harry Thangaraj,*Director, Access to Pharmaceuticals Project: St
George’s University London

Title:*'Health, Patents and Responsibility’*


*3:15 – 3:30     Tea and coffee*

*3:30 – 5.00*      *Session V: Open Science and Open Source*

*Dr Javier Lezaun, *James Martin Lecturer in Science and Technology
Governance, and Deputy Director of the Institute for Science, Innovation
and Society, Oxford Martin School,University of Oxford



Title:*‘Patent Bargains and Drug Discovery’*

*Dr Wenhwa Lee, *Strategic Alliances Manager *Structural Genomics
Consortium, *University of Oxford

Title: *'50 Shades of Grey and Open Innovation: why open access science is
the only way to accelerate drug discovery*'


*Professor Graham Dutfield, **Professor* of International Governance,
*University
of Leeds*

Title: *'Synthetic Biology: Innovation, Patents and Business in an Emerging
Technology'*

*5:00 - 5.10      Closing remarks*



More information about the Ip-health mailing list